Miaoshou Doctor, a Chinese online healthcare services platform that has expanded into the offline pharmacy space, has completed its extended Series C funding round, having achieved a post-deal valuation of more than RMB7 billion ($1 billion).
The company did not disclose the size of the round or identify any of the participants, merely saying it was fully subscribed by existing investors. This follows an announcement in January that Starquest...
WayCool Foods receives $32 million in funding to support an expansion of its agricultural technology proposition that removes middlemen - and boosts efficiency - in food supply chains
Recognizing strong demand trends for electric vehicle batteries, KKR turned around KCF Technologies within two years before exiting the Korean business with a 6.5x return
Anthony Kerwick, a managing director at Australia’s Adamantem Capital, on the coronavirus impact, helping capital constrained companies, and why he avoids using the term ‘proprietary’
Singapore-based Asia Partners has led a $35 million round for Hong Kong online education start-up Snapask. It coincides with the company’s relocation to Singapore.